|
|
| | 7H-Pyrazolo[4,3-d]pyrimidin-7-one, 1,6-dihydro-1-methyl-5-[5-[2-(4-methyl-1-piperazinyl)acetyl]-2-propoxyphenyl]-3-propyl- Basic information |
| | 7H-Pyrazolo[4,3-d]pyrimidin-7-one, 1,6-dihydro-1-methyl-5-[5-[2-(4-methyl-1-piperazinyl)acetyl]-2-propoxyphenyl]-3-propyl- Chemical Properties |
| density | 1.27±0.1 g/cm3(Predicted) | | pka | 10.09±0.20(Predicted) |
| | 7H-Pyrazolo[4,3-d]pyrimidin-7-one, 1,6-dihydro-1-methyl-5-[5-[2-(4-methyl-1-piperazinyl)acetyl]-2-propoxyphenyl]-3-propyl- Usage And Synthesis |
| Uses | A reactant in the preparation of cGMP phosphodiesterase inhibitor. |
| | 7H-Pyrazolo[4,3-d]pyrimidin-7-one, 1,6-dihydro-1-methyl-5-[5-[2-(4-methyl-1-piperazinyl)acetyl]-2-propoxyphenyl]-3-propyl- Preparation Products And Raw materials |
|